The heel prick test performed on newborns is used to screen for congenital hypothyroidism and phenylketonuria, enabling early detection and treatment.

Follow-up and intervention after newborn disease screening for hypothyroidism positive results

Screening shows that the newborn’s thyroid hormone levels are abnormal, which may involve metabolic diseases.

A newborn disease screening PHE result of zero may indicate that the baby does not have congenital phenylketonuria, but further examination and consultation with a doctor are needed to determine the specific situation.

Why does the newborn disease screening PHE show NULL? Should I consult a doctor?

Newborn disease screening aims to detect congenital metabolic diseases such as phenylketonuria early on, through the use of specially formulated low-phenylalanine formula milk for treatment, to prevent irreversible damage to the newborn’s nervous system.

Newborn disease screening is conducted to detect congenital hypothyroidism and phenylketonuria. If the results show no abnormalities, it indicates that the baby does not have either of these two conditions.

Are negative newborn disease screening results normal, and what do the results mean?

The importance of newborn disease screening and the impact of gender errors on test results

Newborn disease screening through laboratory testing can detect congenital metabolic disorders early, preventing intellectual and physical developmental disabilities, and even death. Gender misidentification does not affect the test results.